The global immunoglobulin market was valued at approximately USD 14.62 billion in 2023 and is projected to grow at a CAGR of 7.1% from 2024 to 2032, reaching an estimated USD 27.17 billion by 2032. The market growth is driven by the rising prevalence of immune-related disorders, advancemen